Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

N/ACompletedNCT04019808

Fundación para la Investigación del Hospital Clínico de Valencia800 enrolled

Overview

This study is divided into two parts: Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors. Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

Part 1: to determinate the grade of knowledge of established GC risk factors and identification of attitudes about, GC screening programs at baseline, prior to the intervention though an educational program. Part 2: to generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at 6th, 12th, 24th and at Month 36th.

Study Type

OBSERVATIONAL

Enrollment

800

Conditions

Gastric Cancer

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Part A: Educational Intervention Inclusion criteria * Subjects \>18 years old, from EU and CELAC countries participating in this study. * Has given and signed the IC to participate in this study. Exclusion criteria * Subjects who have received some prior preparation (Cancer Gastric Information). * Subjects who have previous Knowledge in Gastric Cancer (Example, near relatives who have suffered Gastric Cancer Part B: H. pylori Register Inclusion criteria * Subjects ≥18 years old diagnose from H. pylori infection and treated at participant sites * Has given and signed the IC. Exclusion criteria * Subjects with chronic gastritis without confirmed diagnose of H. pylori infection, pathologically of by urease test. * Patient's with CG diagnosis (including gastroesophageal junction cancer).

Locations (8)

Instituto Alexander Fleming

Buenos Aires, Argentina

Pontificia Universidad Católica de Chile

Santiago, Chile

Instituto Nacional de Cancerología

México, Mexico

VU Medical Centre

Amsterdam, Netherlands

Outcomes

Primary Outcomes

knowledge GC risk factors and symptoms

Compare the results obtained through a knowledge of CG risk factors by study-specific questionnaire before and after an educational intervention

Time frame: 3 years

H. pylori prevalence and drug resistance

Generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at months 6th, 12th, 24th and 36th.

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.